Mountford Carolyn, Quadrelli Scott, Lin Alexander, Ramadan Saadallah
Centre for MR in Health, School of Health Sciences, University of Newcastle, Newcastle, New South Wales, Australia; Center for Clinical Spectroscopy, Department of Radiology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
NMR Biomed. 2015 Mar;28(3):291-6. doi: 10.1002/nbm.3239. Epub 2014 Dec 22.
A growing body of literature has indicated that fucose-α(1-2)-galactose sugars are implicated in the molecular mechanisms that underlie neuronal development, learning and memory in the human brain. An understanding of the in vivo roles played by these terminal fucose residues has been hampered by the lack of technology to non-invasively monitor their levels in the human brain. We have implemented in vivo two-dimensional MRS technology to examine the human brain in a 3-T clinical MR scanner, and report that six fucose-α(1-2)-galactose residues and free α-fucose are available for inspection. Fucose-α(1-3)-galactose residues cannot yet be assigned using this technology as they resonate under the water resonance. This new application offers an unprecedented insight into the molecular mechanisms by which fucosylated sugars contribute to neuronal processes and how they alter during development, ageing and disease.
越来越多的文献表明,岩藻糖-α(1-2)-半乳糖糖参与了人类大脑神经元发育、学习和记忆的分子机制。由于缺乏非侵入性监测其在人类大脑中水平的技术,对这些末端岩藻糖残基在体内所起作用的理解受到了阻碍。我们已采用体内二维磁共振波谱技术在3-T临床磁共振扫描仪中检查人类大脑,并报告有六个岩藻糖-α(1-2)-半乳糖残基和游离α-岩藻糖可供检测。岩藻糖-α(1-3)-半乳糖残基目前还不能用该技术进行识别,因为它们与水共振峰重叠。这项新应用为岩藻糖化糖参与神经元过程的分子机制以及它们在发育、衰老和疾病过程中如何变化提供了前所未有的见解。